Literature DB >> 6642340

Forensic significance of postmortem estimation of the blood cerebrospinal fluid barrier permeability.

P Mangin, A A Lugnier, A J Chaumont, M Offner, M Grucker.   

Abstract

Albumin concentration in cerebrospinal fluid (CSF) and plasma was determined in 44 cadavers divided into three groups on the basis of death agony duration. The same was determined in a control group of 42 patients with no demonstrable neurological disease. Following Schuller's method, the evaluation of the blood CSF barrier permeability was based upon the rate of albumin transfer from plasma to CSF. An average increase of 9% in blood CSF barrier permeability was found in cases of a long-duration death agony but not in cases of short-duration death agony (sudden deaths) or in the control group. We consider these results to be related to the hypoxia and hypercapnia which characterize the agonic suffering period. Therefore, we conclude that the postmortem determination of the rate of albumin transfer from plasma to CSF could be a reliable indicator of the duration of the agonic process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6642340     DOI: 10.1016/0379-0738(83)90007-5

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  3 in total

Review 1.  Postmortem bacteriology: a re-evaluation.

Authors:  J A Morris; L M Harrison; S M Partridge
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases.

Authors:  Tze How Mok; Akin Nihat; Connie Luk; Danielle Sequeira; Mark Batchelor; Simon Mead; John Collinge; Graham S Jackson
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Postmortem cerebrospinal fluid pleocytosis: a marker of inflammation or postmortem artifact?

Authors:  James A Morris; Linda M Harrison; David R Telford
Journal:  Int J Pediatr       Date:  2012-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.